多病共存危重成人对康复干预的反应:基于四项随机试验个体汇总数据的患者水平Meta分析
该患者水平Meta分析汇总了四项重症监护物理康复随机对照试验的个体数据,共810例(干预组403例、对照组407例),采用线性混合模型分析。结果显示,合并两种或以上共病的患者接受康复干预后,3个月和6个月时的HRQoL评分显著高于共病情况相似的对照组,且超过最小重要差异(基于躯体成分总结评分,Wald检验P=0.041)。合并一种或无共病的患者接受干预后,3个月和6个月时的HRQoL与对照组无差异。没有任何患者特征改变物理表现结局。作者认为,识别出合并两种或以上共病这一从试验干预中获益的目标人群是重要发现,为未来康复研究提供了方向。
要点
- 在四项ICU康复RCT的810例个体数据中,合并≥2种共病的患者接受康复干预后3个月和6个月HRQoL显著高于共病相似的对照组,且超过最小重要差异(基于躯体成分总结评分,Wald检验P=0.041)。
- 合并1种或无共病的患者接受康复干预后3个月和6个月HRQoL与共病相似的对照组无差异。
- 没有患者特征(包括年龄、性别、疾病严重程度)改变物理表现结局。
- 作者认为,合并≥2种共病的ICU后多病人群可能是未来物理康复前瞻性研究的选定人群。
适用人群与场景
- 四项重症监护物理康复随机对照试验的个体患者数据,共810例(干预组403例、对照组407例)。
- 根据共病数量分为合并≥2种共病与合并1种或无共病两个亚组进行分析。
研究设计与关键结果
- 研究设计:患者水平Meta分析,汇总四项重症监护物理康复随机对照试验的个体数据,使用线性混合模型拟合治疗组、时间和试验的固定效应。
- 样本量:共810例患者,干预组403例、对照组407例。
- 主要终点HRQoL:合并≥2种共病的患者接受康复干预后3个月和6个月HRQoL评分显著高于共病相似的对照组,且超过最小重要差异(基于躯体成分总结评分,Wald检验P=0.041)。
- 合并1种或无共病的患者接受干预后3个月和6个月HRQoL与共病相似的对照组无差异。
- 次要终点物理表现:没有患者特征改变物理表现结局。
证据类型、等级与局限
- 证据类型:基于四项随机对照试验个体数据的患者水平Meta分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,识别出合并两种或以上共病这一从试验干预中获益的目标人群是重要发现,为未来康复研究提供了方向;合并≥2种共病的ICU后多病人群可能是未来物理康复前瞻性研究的选定人群。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore if patient characteristics (pre-existing comorbidity, age, sex, and illness severity) modify the effect of physical rehabilitation (intervention vs control) for the coprimary outcomes health-related quality of life (HRQoL) and objective physical performance using pooled individual patient data from randomized controlled trials (RCTs).
DATA SOURCES: Data of individual patients from four critical care physical rehabilitation RCTs.
STUDY SELECTION: Eligible trials were identified from a published systematic review.
DATA EXTRACTION: Data sharing agreements were executed permitting transfer of anonymized data of individual patients from four trials to form one large, combined dataset. The pooled trial data were analyzed with linear mixed models fitted with fixed effects for treatment group, time, and trial.
DATA SYNTHESIS: Four trials contributed data resulting in a combined total of 810 patients (intervention n = 403, control n = 407). After receiving trial rehabilitation interventions, patients with two or more comorbidities had HRQoL scores that were significantly higher and exceeded the minimal important difference at 3 and 6 months compared with the similarly comorbid control group (based on the Physical Component Summary score (Wald test p = 0.041). Patients with one or no comorbidities who received intervention had no HRQoL outcome differences at 3 and 6 months when compared with similarly comorbid control patients. No patient characteristic modified the physical performance outcome in patients who received physical rehabilitation.
CONCLUSIONS: The identification of a target group with two or more comorbidities who derived benefits from the trial interventions is an important finding and provides direction for future investigations into the effect of rehabilitation. The multimorbid post-ICU population may be a select population for future prospective investigations into the effect of physical rehabilitation.
参考来源
- Jones JRA, Karahalios A, Puthucheary ZA, et al. Responsiveness of Critically Ill Adults With Multimorbidity to Rehabilitation Interventions: A Patient-Level Meta-Analysis Using Individual Pooled Data From Four Randomized Trials. Crit Care Med. 2023. PMID: 37246922. doi:10.1097/CCM.0000000000005936
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。